Seizures and epilepsy FOR clinical pharmacy student
By Dr. Hussein Abdeldayem, MD
Professor of Pediatric Neurology Unit
Faculty of medicine, Alex University
FOR CLINICAL PHARMACY STUDENTS
Childhood Seizures and
epilepsy
AED
Seizures
• Seizure /epilepsy in children is one
of the most anxiety-provoking
conditions for parents and a
common reason for emergency
department visits
Seizure
: the involuntary clinical manifestation (S &/or S)
due to an abnormal and excessive excitation
and synchronization of a population of cortical
neurons
Seizure is anSeizure is an ACUTEACUTE
ManifestationManifestation
Epilepsy is aEpilepsy is a ChronicChronic
DISEASEDISEASE
• The clinical efficacy of benzodiazepines
for management of seizure clusters is
due to their ability to bind with high
affinity to which of the following types
of receptor sites?
• Dopaminergic 2
• γ-aminobutyric acid A (GABAA)
• Nicotinic acetylcholine
• Sphingosine-1 phosphate
Rectal Diazepam*
• The absorption of oral diazepam is slow
(1-2 hours) and variable.
• Intramuscular diazepam has similar
absorption problems, is painful and may
cause muscle necrosis.
• Suppositories have slow and variable
absorption rates and are not
recommended in an emergency.
Rectal administration of the intravenous form of diazepam
Rectal Diazepam*
• Intravenous and rectal diazepam both stop
seizures in more than 80% of cases within
10-15 minutes
Less Resp Depression
Less BP Depression
Less CNS Depression
Prolonged action
Rectal Diazepam
• Use IV ampoules (10mg/2ml) or gel
• Use Insulin syringes*
• Rectal administration (use lubricant)
Dose: 0.5 MG/KG max: 10 mg
Lubrication
Diazepam adsorbs to plastic and thus needs to be stored in glass
Classification according to EEG findings
GeneralizedGeneralized FocalFocal
Both Cerebral
Hemispheres
Only a part of a
hemisphere
Loss of Consciousness No loss of
consciousness
Treated by Valproate Treated by
Carbamazipine
MRIMRI
Focal withFocal with
2ry G2ry G
Pediatric Seizures
Seizure Type Classification
3- Clinically (ILAE 1981)
GENERALIZED
1- Involves both cerebral
hemispheres
2- Loss consciousness
2- EEG: generalized
3- no aura
FOCAL (PARTIAL)
1- involve one
hemisphere
2- NO Loss of consciousness
3- EEG: focal activity
4- ± aura
Partial (focal) with
secondary generalization
Partial (focal) with
secondary generalization
± MRI
ASKMRIASKMRI
Practical points
Stop attacks with no S/EStop attacks with no S/E
Start with minimal doseStart with minimal dose
duration : 2years from last attackduration : 2years from last attack
withdraw slowly for 3 monthswithdraw slowly for 3 months
DON’T CHANGE COOKERDON’T CHANGE COOKER
TreatmentTreatment
35
Would u treat first seizure?
• In children , we can wait for second attack
for epilepsy diagnosis (chronicity)
(Valproate)
• 20 – 60 mg/kg/d
• Twice*
• Forms
Oral with dropper
Oral with spoon
200 mg tablets
500 mg chrono tablets
• Follow up of:
Serum drug level (peak)
Serum drug level (trough)
SGOT, SGPT, PT
(Carbamazepine)
• 10 – 20 mg/kg/d*
• Twice
• Forms
Oral (100 mg/5ml)
200 mg tablets
200 mg CR tablets
400 mg CR tablets
• Follow up of:
Serum drug level (peak)
Serum drug level (trough)
Blood CBC
Levetiracetam
• Dose
• Children: weight/10 ml twice
• Therapeutic plasma concentration
• Not relevant
• Indicated for
ALL
• Common side effects
• Nausea, drowsiness, anorexia,
headache, rash,
• Very rarely leucopenia
• Comments
• No drug interactions described
• 20 – 60 mg/kg/d
• Twice
• Forms:
Oral: (100mg/1ml)
500 mg tablets
• Blood Follow up: NONE
• Onset of action
• Add on, no drug interaction
* Not before 4 years age
(Levetiracetam)
• Quick onset of action
• No cognitive S/E
• Bind specific CNS areas only as hippocampus
• Not liver metabolism, not protein binding so not interact
with other AED
The starting dose of 20mg/kg/day was increased
at intervals of 1 week by 10mg/kg/day,
if necessary, up to a maximum dose of 60mg/kg/day.
Steady state: 8hX5
FDA approval for levetiracetam in infants and
children from one month of age with partial
onset seizures
January 26, 2012
Levetiracetam
LEV is effective against post-stroke seizures
LEV IS EFFECTIVE IN SE
Brain Dev. 2010 Jul 12.
Levetiracetam in brain ischemia: Clinical implications
in neuroprotection and prevention of post-stroke epilepsy.
• 10 – 20 mg/kg/d*
• Twice
• Forms
Oral (100 mg/5ml)
200 mg tablets
200 mg CR tablets
400 mg CR tablets
• Follow up of:
Serum drug level (peak)
Serum drug level (trough)
Blood CBC
• 20 – 60 mg/kg/d
• Twice
• Forms:
Oral: (100mg/1ml)
250 mg tablets
500 mg tablets
• Follow up: NONE
* Not before 4 years age
• 20 – 60 mg/kg/d
• Twice*
• Forms
Oral with dropper
Oral with spoon
200 mg tablets
500 mg chrono tablets
• Follow up of:
Serum drug level (peak)
Serum drug level (trough)
SGOT, SGPT, PT
(Valproate) ( Carbamazepine) (Levetiracetam)
44
Why don’t patients comply?
• Poor communication or information
• Poor understanding of instructions
• Cost
• Side effects +
• Poor dose regimes +
• Difficult to swallow/nasty taste
medication +
Good information makes medicines
work
45
AEDs
• First-generation AEDs include
phenobarbitone, phenytoin,
carbamazepine, valproic acid
clonazepam, and primidone
• Since early 1990’s: lamotrigine,
gabapentin, oxcarbazepine, levetiracetam,
divalproex sodium, topiramate,
zonisamide, vigabatrin, tiagabine, and
felbamate
• The latest AEDs to become available are
pregabalin, lacosimide, and rufinimide.
46
Drugs that cause seizures
• Chemotherapeutic agents: intrathecal
MTX, L-aspariginase, chlorambucil
• Immunosuppressants: cyclosporinA
• Anti-infective agents: high dose penicillins,
metronidazole
• Antipsychotic/AD: phenothiazines, tricyclic
antidepressant
• Sympathomimetic as in cold therapy and
antitussive drugs
• Theophylline
47
Principles of drug usage
• Monotherapy
• Least dosage
• First choice
• Compliance: cost, dosage division, formula
• Least S/E especially cognitive functions
48
AE S/E
5+1
• CNS S/E: drowsiness, irritability, headache, ataxia,
tremors
• GIT S/E: anorexia, abdominal pain, increase or decrease
appetite
• Dermal S/E; urticarial up to Steven Johnson syndrome
and anaphylaxis
• BM S/E: suppression (WBC,RBC, Platelets)
• Teratogenic : especially valproate (neural tube defect)
• + specific S/E
•
54
Phenytoin and
GINGIVAL HYPERPLASIA
• Etiology: ?
(fibroblasts ↑ in
CT)
• Any age ( > in
younger)
• Male=female
• Not depend in
dosage
• Strong correlation
with dental
hygiene
• Usually between
2-18 months
55
Phenytoin and
GINGIVAL HYPERPLASIA
• EFFECT of Tissue
overgrowth
1- delayed eruption
2-misalignment
3- retention of food and
halitosis
4- disfigurement
Treatment
1- dental hygiene
2- night gingival +ve
pressure appliance
3- gingivectomy
Children with seizures are often referred to the emergency department where they are typically evaluated by a physician with limited knowledge of pediatric epileptology and undergo a costly and extensive work-up that contributes little to the final decision
1 in every 10 persons will experience a seizure at some time in their lifetime. 1 in every 100 persons will experience epilepsy
resulting from excessive and abnormal discharge of cortical neurons
Keep calm and Reassure care giver
1- lateral position and raise legs
2-Loosen clothing around neck and body
3- Ensure area around child is clear and safe
* > 5 min
50 ml G50%
B6 for infancy
S spine
Toxicology study ( blood and urine)
Lorazepam longer action and less resp depression 4mg/1ml
Midazolam : IV, IM , intranasal, buccal, rectal
DZP ; Iv, rectal (gel of solution and not suppositories) / diastat (rectal gel) not suppository
diazepam acts to suppress seizures through an interaction with (gamma)-aminobutyric acid (GABA) receptors of the A-type (GABA A )
*use DZP gel (diastat) or IV solution
Indication 1- severe epilepsy
2- with clusters (serial) seizures
3- prolonged seizures >5mg
Diazepam given rectally appears to be as effective as intravenous diazepam in terminating seizures. It may have advantages, including more prolonged action (20-30 minutes compared to 10-20 minutes), Time to peak plasma levels after rectal administration (about 5-10 minutes) is longer than after intravenous injection (1-3 minutes). This time difference may be important in status epilepticus where rapid seizure termination is necessary. It also possibly explains the lower incidence of respiratory depression experienced with rectal administration. The prolonged action after rectal administration may prevent seizure recurrence and allow more time to seek medical assistance.
Diazepam gel (diastat) or
The breaking of ampoules (10 mg/2 mL) and the use of needles by non-medical carers can be difficult and dangerous. If it is necessary to dilute diazepam, it is important to dilute it correctly as certain volumes of normal saline or dextrose can result in the precipitation of diazepam. Some institutions like the Royal Children's Hospital in Melbourne prepare 25 mL bottles of a rectal solution (1 mg/mL) using 50% propylene glycol in water. This is easy to use and does not expire for one year.3 Diazepam adsorbs to plastic and thus needs to be stored in glass. There are anecdotal reports of using diazepam oral mixture rectally, but its efficacy is not proven and thus cannot be recommended. Oil in water emulsions of injectable diazepam (e.g. Diazemuls) are slowly absorbed rectally and thus are inappropriate to use.
A lubricated and suitably soft rectal tube is necessary as there are reports of hard plastic nozzles damaging the rectum. It is recommended that the tube or syringe is introduced only 4-5 cm into the rectum. Theoretically, administration of drugs higher into the rectum may result in greater first-pass metabolism, but clinically this is of minimal importance with rectal diazepam.
If possible, infants and toddlers should be placed prone for rectal diazepam to be administered. Older children should be positioned on their side, in the recovery position. After administration, keep the child in the same position and hold the buttocks together for a few minutes to limit leakage from the rectum.
There are two classes of GABA receptors: GABA-A and GABA-B.
GABA – A Stimulation: Activation leads to membrane hyperpolarization via inflow of Cl and outflow K
Decreased neuronal firing
1 in every 10 persons will experience a seizure at some time in their lifetime. 1 in every 100 persons will experience epilepsy
resulting from excessive and abnormal discharge of cortical neurons
Aim : to stop attacks No attacks / No S/E
Start with minimal dose and increase gradually
Stop if side effects appeared
Don’t withdraw AED suddenly but gradually
Do not change cooker
After 48 hrs , LVT will start main effect.
Levetiracetam is one of the agents that has a short half-life, has a half-life of about 7- 8 hours; but its pharmacodynamic action may extend considerably beyond that. If an agent has a short half-life, it only takes 5 half-lives to reach a steady state
Keppra® was previously approved in the U.S. as adjunctive therapy for partial onset seizures in adults and children four years of age and older with epilepsy.
levetiracetam is both safe and effective against post-stroke seizures due to the potential neuroprotective role in brain ischemia